PACB

Pacific Biosciences Of California Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth↑ 7/10
  • Value↓ 0/10
Pacific Biosciences Of California sales and earnings growth
PACB Growth
Good
  • Revenue Y/Y↓ 3.59%
  • EPS Y/Y↑ 81.14%
  • FCF Y/Y↑ 62.83%
Pacific Biosciences Of California gross and profit margin trends
PACB Profitability
Fair
  • Gross margin ↑ 37.50%
  • EPS margin↓ -80.30%
  • ROIC 5Y↓ -30.22%
Pacific Biosciences Of California net debt vs free cash flow
PACB Risk
Poor
  • Debt / Equity↑ 297.3
  • Debt / FCF↑ 9.8
  • Interest coverage↓ -17.4

Pacific Biosciences Of California stock volatility is higher than the overall market. We give it a Poor risk rating.

↗ More Medical Devices stocks